Freeport-McMoRan Inc. buy BNP Paribas Exane
Start price
17.09.25
/
50%
€38.21
Target price
17.09.26
€47.24
Performance (%)
32.43%
Price
16.01.26
€50.60
Summary
This prediction is currently active. The BUY prediction by BNP_Paribas_Exane for Freeport-McMoRan Inc. has seen massive gains of 32.43%. This prediction currently runs until 17.09.26. The prediction end date can be changed by BNP_Paribas_Exane at any time. BNP_Paribas_Exane has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Freeport-McMoRan Inc. | 4.190% | 4.190% |
| iShares Core DAX® | 0.191% | 4.771% |
| iShares Nasdaq 100 | -0.614% | 3.137% |
| iShares Nikkei 225® | 0.599% | 8.016% |
| iShares S&P 500 | -0.036% | 3.593% |
Comments by BNP_Paribas_Exane for this prediction
In the thread Discuss Freeport-McMoRan Inc.
Freeport-McMoRan (NYSE:FCX) had its price target raised by analysts at BNP Paribas Exane from $52.00 to $56.00. They now have an "outperform" rating on the stock.
Ratings data for FCX provided by MarketBeat
Stopped prediction by BNP_Paribas_Exane for Freeport-McMoRan Inc.
Freeport-McMoRan Inc.
Start price
Target price
Perf. (%)
€39.09
05.12.25
05.12.25
€48.05
05.12.26
05.12.26
29.46%
16.01.26
16.01.26
Freeport-McMoRan Inc.
Start price
Target price
Perf. (%)
€30.87
25.09.25
25.09.25
€44.28
25.09.26
25.09.26
63.91%
16.01.26
16.01.26